Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Enhance MD vs Found

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Enhance MD logo

Enhance MD

8.5
★★★★4.3/5

Best for: knowing which pharmacy fills the vial — it names Tru Meds Rx

Visit Enhance MD
VS
Found logo

Found

8.8
★★★★4.4/5

Best for: tirzepatide at $169/month, 37% under the register median

Visit Found

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, Found opens cheaper — $149/mo against $169, and Found finishes ahead, 8.8 to 8.5. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

Enhance MD

GLP-1 CoreCompounded
$212$112/mo
Save 47% right now
semaglutide

$212/mo is the 12-month-plan rate (billed every 48 weeks). 6-mo $224/mo, 3-mo $237/mo, 1-mo $249/mo. First month $112 = $100 off first order on 3+ month plans (code SUMMER100); $50 off 1-month (SUMMER50). Flat price at all doses; labs, consult, 2-day shipping included.

GLP-1 AdvancedCompounded
$280$180/mo
Save 36% right now
tirzepatide

$280/mo = 12-month-plan rate. 6-mo $296/mo, 3-mo $313/mo, 1-mo $329/mo. First month $180 via $100-off first order (SUMMER100). Flat all-dose pricing.

GLP-1 Elite (sema + tirz)Compounded
$322$222/mo
Save 31% right now
tirzepatide

Combined semaglutide + tirzepatide. $322/mo = 12-month-plan rate. 6-mo $341/mo, 3-mo $360/mo, 1-mo $379/mo. First month $222 via SUMMER100.

Microdosing Tirzepatide (NEW product)Compounded
$169/mo
tirzepatide

New low-dose tier: 12-mo $169/mo, 6-mo $179/mo, 3-mo $189/mo; the 1-month plan's price is not displayed on the page (blank slot) — not published. No $100-off promo tags shown on this product's plan picker.

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

What’s included

Enhance MD

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

In the price

Coaching

Not stated

Found

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Enhance MD

8.5/10

Overall

Found

8.8/10

Value25%

8.3A
vs
B
8.3

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

7.0A
vs
B
8.0

Trust & Safety15%

9.0A
vs
B
8.5

Accessibility10%

8.2A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

Features & Coverage

FeatureEnhance MDFound
Starting Price$169/mo$149/mo
Features6 features3 features
States Available3950
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About Enhance MD

$112 buys the first month on Core, once $100 comes off the opening order with code SUMMER100. Core is the semaglutide tier, Advanced is tirzepatide, Elite combines the two. Before any of that, Enhance MD requires two mandatory steps: baseline metabolic labs, drawn at Quest Diagnostics, then a live video visit with a board-certified clinician. Most sellers in compounded GLP-1s onboard asynchronously and ask for neither, so this is the more rigorous route in.

Read our full Enhance MD review →

About Found

Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.

Read our full Found review →

Pros & Cons

Enhance MD

What we like

  • Tirzepatide at $169 a month, 37% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, labs
  • Names 3 dispensing pharmacies, which most sellers in this register do not do
  • No FDA warning letter matched this operator when we searched our enforcement register
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
  • Baseline bloodwork is required before a prescription

Watch-outs

  • Coverage is published for 39 states only, so this may not reach you
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Found

What we like

  • Tirzepatide at $169 a month, 37% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, coaching
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its orforglipron and semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Found

Found takes it, 8.8 against 8.5, and it is especially strong on tirzepatide at $169/month, 37% under the register median. Enhance MD is no weak second and may fit you better on knowing which pharmacy fills the vial — it names Tru Meds Rx.

Choose Enhance MD if…

You want knowing which pharmacy fills the vial — it names Tru Meds Rx and an opening price near $169 a month.

Choose Found if…

You want tirzepatide at $169/month, 37% under the register median and an opening price near $149 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.0

MyDrHank

An oral route if you will not self-inject

6.0

SkinnyRx

Starting below a standard dose, with microdose tiers

8.2

YourEra

Semaglutide at $99/month, 63% under the register median

Enhance MD vs Found: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring Enhance MD and Found head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.